{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:17:39Z","timestamp":1786997859870,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT093092MA"],"award-info":[{"award-number":["WT093092MA"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hotung Foundation","award":["ERC-2010-AdG_20100317"],"award-info":[{"award-number":["ERC-2010-AdG_20100317"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2018.02.057","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T08:53:47Z","timestamp":1520326427000},"page":"4673-4680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["In vitro and in vivo evaluation of a single chain antibody fragment generated in planta with potent rabies neutralisation activity"],"prefix":"10.1016","volume":"37","author":[{"given":"Waranyoo","family":"Phoolcharoen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley C.","family":"Banyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Prehaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Selden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin P.D.","family":"Birch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim H.","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Lafon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Fooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian K.-C.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.02.057_b0005","doi-asserted-by":"crossref","unstructured":"Dietzgen RG, et al., Family rhabdoviridae. In: King AMQ, et al., editors. Virus taxonomy: ninth report of the international committee on taxonomy of viruses. 2011 Elsevier Academic Press. p. 686\u2013714.","DOI":"10.1016\/B978-0-12-384684-6.00057-4"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.057_b0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2260","article-title":"The cell biology of rabies virus: using stealth to reach the brain","volume":"8","author":"Schnell","year":"2010","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2018.02.057_b0015","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3201\/eid1412.080944","article-title":"Human rabies case with long incubation, Australia","volume":"14","author":"Johnson","year":"2008","journal-title":"Emerging Infect Diseases"},{"key":"10.1016\/j.vaccine.2018.02.057_b0020","unstructured":"WHO, WHO Expert Consultation on Rabies, in World Health Organ Tech Rep Ser WHO, Editor. 2013. p. 1\u2013139."},{"issue":"5","key":"10.1016\/j.vaccine.2018.02.057_b0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1473-3099(11)70340-1","article-title":"Passive immunity in the prevention of rabies","volume":"12","author":"Both","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2018.02.057_b0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/B978-0-12-387040-7.00013-5","article-title":"Postexposure prophylaxis for rabies in resource-limited\/poor countries","volume":"79","author":"Shantavasinkul","year":"2011","journal-title":"Adv Virus Res"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.057_b0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/cid\/cis384","article-title":"Rabies postexposure prophylaxis in routine practice in view of the new Centers for Disease Control and Prevention and World Health Organization recommendations","volume":"55","author":"Uwanyiligira","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.057_b0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1474-4422(02)00041-8","article-title":"Human rabies: a disease of complex neuropathogenetic mechanisms and diagnostic challenges","volume":"1","author":"Hemachudha","year":"2002","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.vaccine.2018.02.057_b0045","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/(SICI)1097-4598(200005)23:5<720::AID-MUS9>3.0.CO;2-5","article-title":"Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures","volume":"23","author":"Lewis","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.vaccine.2018.02.057_b0050","first-page":"765","article-title":"Studies on the local treatment of Wounds for the prevention of rabies","volume":"26","author":"Kaplan","year":"1962","journal-title":"Bull WHO"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2018.02.057_b0055","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0264-410X(00)00516-8","article-title":"The incurable wound revisited: progress in human rabies prevention?","volume":"19","author":"Hanlon","year":"2001","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2018.02.057_b0060","doi-asserted-by":"crossref","first-page":"S766","DOI":"10.1093\/clinids\/10.Supplement_4.S766","article-title":"Use of serum and vaccine in combination for prophylaxis following exposure to rabies","volume":"10","author":"Fangtao","year":"1988","journal-title":"Rev Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.057_b0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/10611860903548354","article-title":"Biopharmaceutical drug targeting to the brain","volume":"18","author":"Pardridge","year":"2010","journal-title":"J Drug Target"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.057_b0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/13550280590900427","article-title":"Rabies virus receptors","volume":"11","author":"Lafon","year":"2005","journal-title":"J Neurovirol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.057_b0075","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0923-2494(93)80121-E","article-title":"Rabies virus superantigen","volume":"144","author":"Lafon","year":"1993","journal-title":"Res Immunol"},{"key":"10.1016\/j.vaccine.2018.02.057_b0080","first-page":"57","article-title":"Synthetic peptides in the study of the interaction of rabies virus and the acetylcholine receptor","volume":"44","author":"Lentz","year":"1988","journal-title":"Adv Biochem Psychopharmacol"},{"issue":"4529","key":"10.1016\/j.vaccine.2018.02.057_b0085","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1126\/science.7053569","article-title":"Is the acetylcholine receptor a rabies virus receptor?","volume":"215","author":"Lentz","year":"1982","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.057_b0090","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0168-1702(85)90014-0","article-title":"Rabies virus binding at neuromuscular junctions","volume":"2","author":"Burrage","year":"1985","journal-title":"Virus Res"},{"issue":"4","key":"10.1016\/j.vaccine.2018.02.057_b0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/prot.340020406","article-title":"Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor","volume":"2","author":"Lentz","year":"1987","journal-title":"Proteins"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.057_b0100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jmr.300030205","article-title":"Rabies virus binding to an acetylcholine receptor alpha-subunit peptide","volume":"3","author":"Lentz","year":"1990","journal-title":"J Mol Recognit"},{"issue":"7149","key":"10.1016\/j.vaccine.2018.02.057_b0105","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2018.02.057_b0110","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.biomaterials.2012.09.047","article-title":"Brain-targeted delivery of protein using chitosan- and RVG peptide-conjugated, pluronic-based nano-carrier","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2018.02.057_b0115","doi-asserted-by":"crossref","unstructured":"Hwang do W, et al. A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. Biomaterials 2011; 32(21): 4968\u201375.","DOI":"10.1016\/j.biomaterials.2011.03.047"},{"issue":"8","key":"10.1016\/j.vaccine.2018.02.057_b0120","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3109\/1061186X.2010.523788","article-title":"Targeted delivery of large fusion protein into hippocampal neurons by systemic administration","volume":"19","author":"Xiang","year":"2011","journal-title":"J Drug Target"},{"issue":"6","key":"10.1016\/j.vaccine.2018.02.057_b0125","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1007\/s11095-012-0667-y","article-title":"Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide","volume":"29","author":"Fu","year":"2012","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.vaccine.2018.02.057_b0130","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1371\/journal.pntd.0000542","article-title":"Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans","volume":"3","author":"Muller","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2018.02.057_b0135","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1096\/fj.12-219964","article-title":"Production, characterization, and antigen specificity of recombinant 62\u201371-3, a candidate monoclonal antibody for rabies prophylaxis in humans","volume":"27","author":"Both","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/j.vaccine.2018.02.057_b0140","doi-asserted-by":"crossref","DOI":"10.1111\/pbi.12719","article-title":"Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood-brain barrier device","author":"Phoolcharoen","year":"2017","journal-title":"Plant Biotechnol J"},{"issue":"10","key":"10.1016\/j.vaccine.2018.02.057_b0145","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/pbi.12719","article-title":"Enhanced transport of plant-produced rabies single-chain antibody-RVG peptide fusion protein across an in cellulo blood-brain barrier device","volume":"15","author":"Phoolcharoen","year":"2017","journal-title":"Plant Biotechnol J"},{"issue":"4","key":"10.1016\/j.vaccine.2018.02.057_b0150","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/bit.22299","article-title":"A DNA replicon system for rapid high-level production of virus-like particles in plants","volume":"103","author":"Huang","year":"2009","journal-title":"Biotechnol Bioeng"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.057_b0155","doi-asserted-by":"crossref","first-page":"e16519","DOI":"10.1371\/journal.pone.0016519","article-title":"Characterizing ligand-gated ion channel receptors with genetically encoded Ca2++ sensors","volume":"6","author":"Yamauchi","year":"2011","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.vaccine.2018.02.057_b0160","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","article-title":"Blood-brain barrier-specific properties of a human adult brain endothelial cell line","volume":"19","author":"Weksler","year":"2005","journal-title":"FASEB J"},{"issue":"10","key":"10.1016\/j.vaccine.2018.02.057_b0165","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1128\/JVI.71.10.7372-7380.1997","article-title":"Rabies virus infects mouse and human lymphocytes and induces apoptosis","volume":"71","author":"Thoulouze","year":"1997","journal-title":"J Virol"},{"issue":"46\u201347","key":"10.1016\/j.vaccine.2018.02.057_b0170","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1016\/j.vaccine.2005.06.027","article-title":"Immunopotentiation of the antibody response against influenza HA with apoptotic bodies generated by rabies virus G-ERA protein-driven apoptosis","volume":"23","author":"Megret","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.057_b0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/2045-8118-10-33","article-title":"Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC\/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies","volume":"10","author":"Eigenmann","year":"2013","journal-title":"Fluids Barriers CNS"},{"issue":"11","key":"10.1016\/j.vaccine.2018.02.057_b0180","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1073\/pnas.93.11.5653","article-title":"Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America","volume":"93","author":"Morimoto","year":"1996","journal-title":"Proc Natl Acad Sci United States Am"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.057_b0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2010.11.015","article-title":"Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC\/D3 cell line","volume":"77","author":"Markoutsa","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.vaccine.2018.02.057_b0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ddtec.2016.07.005","article-title":"Liposome technologies and drug delivery to the CNS","volume":"20","author":"Rip","year":"2016","journal-title":"Drug Discov Today Technol"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.057_b0195","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/jbm.a.35961","article-title":"Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications","volume":"105","author":"Portioli","year":"2017","journal-title":"J Biomed Mater Res A"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.057_b0200","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1038\/s41598-017-03123-y","article-title":"Pluronic F127 and D-alpha-Tocopheryl Polyethylene Glycol Succinate (TPGS) mixed micelles for targeting drug delivery across the blood brain barrier","volume":"7","author":"Meng","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.057_b0205","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/toxsci\/kfv176","article-title":"Gold nanoparticles increase endothelial paracellular permeability by altering components of endothelial tight junctions, and increase blood-brain barrier permeability in mice","volume":"148","author":"Li","year":"2015","journal-title":"Toxicol Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.057_b0210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/mp900235k","article-title":"Pharmacokinetics and brain uptake of a genetically engineered bifunctional fusion antibody targeting the mouse transferrin receptor","volume":"7","author":"Boado","year":"2010","journal-title":"Mol Pharm"},{"issue":"1","key":"10.1016\/j.vaccine.2018.02.057_b0215","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuron.2013.10.061","article-title":"Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle","volume":"81","author":"Niewoehner","year":"2014","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.057_b0220","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1084\/jem.20131660","article-title":"Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants","volume":"211","author":"Bien-Ly","year":"2014","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2018.02.057_b0225","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1016244500596","article-title":"Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate","volume":"12","author":"Pardridge","year":"1995","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.vaccine.2018.02.057_b0230","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/bit.21602","article-title":"Genetic engineering of a lysosomal enzyme fusion protein for targeted delivery across the human blood-brain barrier","volume":"99","author":"Boado","year":"2008","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2018.02.057_b0235","doi-asserted-by":"crossref","first-page":"11990","DOI":"10.1038\/srep11990","article-title":"LRP-1-mediated intracellular antibody delivery to the Central Nervous System","volume":"5","author":"Tian","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2018.02.057_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2017.04.080","article-title":"Routes for drug translocation across the blood-brain barrier: exploiting peptides as delivery vectors","author":"Kristensen","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2018.02.057_b0245","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jconrel.2016.03.020","article-title":"Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems","volume":"229","author":"Zhang","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2018.02.057_b0250","first-page":"4919","article-title":"Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches","volume":"10","author":"Velasco-Aguirre","year":"2015","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.vaccine.2018.02.057_b0255","doi-asserted-by":"crossref","unstructured":"Zou Z, et al. Cre fused with RVG peptide mediates targeted genome editing in mouse brain cells in vivo. Int J Mol Sci; 2016 17(12).","DOI":"10.3390\/ijms17122104"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.057_b0260","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/pbi.12137","article-title":"Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco","volume":"12","author":"Teh","year":"2014","journal-title":"Plant Biotechnol J"},{"issue":"3","key":"10.1016\/j.vaccine.2018.02.057_b0265","first-page":"221","article-title":"Synthetic peptides of neurotoxins and rabies virus glycoprotein behave as antagonists in a functional assay for the acetylcholine receptor","volume":"2","author":"Donnelly-Roberts","year":"1989","journal-title":"Pept Res"},{"issue":"4","key":"10.1016\/j.vaccine.2018.02.057_b0270","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/tmi.12668","article-title":"The dilemma of managing human rabies encephalitis","volume":"21","author":"Warrell","year":"2016","journal-title":"Trop Med Int Health"},{"issue":"7","key":"10.1016\/j.vaccine.2018.02.057_b0275","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1074\/jbc.M109.081828","article-title":"Cross-species binding analyses of mouse and human neonatal Fc receptor show dramatic differences in immunoglobulin G and albumin binding","volume":"285","author":"Andersen","year":"2010","journal-title":"J Biol Chem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18302445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T21:19:42Z","timestamp":1603919982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18302445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":55,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X18302445"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and in vivo evaluation of a single chain antibody fragment generated in planta with potent rabies neutralisation activity","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.02.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}